Patents Assigned to EOSVISION MEDTECH TECHNOLOGY CO., LTD.
  • Publication number: 20240342339
    Abstract: The present application relates to a method for preparing a pegylated collagen-like protein and the use thereof. The method includes reacting a collagen-like protein and a polyethylene glycol derivative at a molar ratio of the collagen-like protein to the polyethylene glycol derivative of 1 to 16:1 under the conditions of a pH of 6.0-8.0 and a temperature of 2-8° C. to prepare a pegylated collagen-like protein. In some embodiments, the reacting includes a reaction solvent of the collagen-like protein, and the polyethylene glycol derivative is water or a dilute hydrochloric acid solution. In some instances, the method may additionally include a purification step. The purification step may intercept substances with a molecular weight greater than or equal to 30,000 Da in the reaction product by filtration to obtain the PEGylated collagen-like protein.
    Type: Application
    Filed: June 20, 2022
    Publication date: October 17, 2024
    Applicant: EOSVISION MEDTECH TECHNOLOGY CO., LTD.
    Inventors: Chongyu WANG, Jiahui ZHANG, Jun ZHANG, Murong LIU, Chaoxian HE